4/A//SEC Filing
McDevitt Damien 4/A
Accession 0001209191-20-021951
CIK 0001662524other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 8:41 PM ET
Size
7.7 KB
Accession
0001209191-20-021951
Insider Transaction Report
Form 4/AAmended
McDevitt Damien
Director
Transactions
- Award
Common Stock
2020-03-19+60,000→ 260,000 total - Award
Stock Option (right to buy)
2020-03-19+120,000→ 120,000 totalExercise: $12.76Exp: 2030-03-18→ Common Stock (120,000 underlying)
Footnotes (4)
- [F1]Due to a typographical error, the number of shares was incorrectly reported on the original Form 4 as 55,200 shares.
- [F2]Represents restricted stock unit award granted under the Issuer's 2015 Equity Incentive Plan.
- [F3]Due to a typographical error, the number of shares was incorrectly reported on the original Form 4 as 109,800 shares.
- [F4]The shares vest as follows: 1/4th of the shares vest one year after March 19, 2020;1/48th of the shares vest monthly thereafter over the next three years.
Documents
Issuer
AKCEA THERAPEUTICS, INC.
CIK 0001662524
Entity typeother
Related Parties
1- filerCIK 0001742277
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 8:41 PM ET
- Size
- 7.7 KB